| Literature DB >> 33058019 |
Jennifer Scott1, Ukachukwu O Abaraogu2,3, Graham Ellis4, Maria Giné-Garriga5,6, Dawn A Skelton2.
Abstract
PURPOSE: The purpose of this review was to identify, evaluate and synthesise existing evidence reporting the physical activity levels of acutely ill older patients in a 'Hospital At Home' setting and compare this to patients with similar characteristics treated in a traditional hospital inpatient setting. Functional changes and any adverse outcomes due to physical activity (e.g. falls) in both settings where PA was reported or recorded were also evaluated as secondary outcomes.Entities:
Keywords: Accelerometry; Aged; Hospital at home; Physical activity; Systematic review
Year: 2020 PMID: 33058019 PMCID: PMC7557152 DOI: 10.1007/s41999-020-00414-y
Source DB: PubMed Journal: Eur Geriatr Med ISSN: 1878-7649 Impact factor: 1.710
Inclusion and exclusion criteria
| Inclusion criteria | Exclusion criteria | |
|---|---|---|
| Setting | Acute medical inpatient or HAH environment | Post-discharge/step-down HAH Pre/post-surgical wards Palliative/end of life care Respite, rehabilitation or recuperation wards Long term care/residential care Mental health admissions |
| Population | Diagnosed with an acute-onset medical condition falling within the scope of an HAH Service | Over 10% of patients admitted for conditions that would not be managed within a HAH setting such as stroke, acute coronary syndromes, surgical or orthopaedic emergencies |
| Outcome measures | Objectively/subjectively measures amount of physical activity performed by patients while admitted |
Fig. 1PRISMA flow diagram [21]
Fig. 2Domain-based risk of bias assessment across all studies
Active time recorded over 24 h
| Study (location) | Participant information | Length of stay (days), disease characteristics | Device, duration of monitoring | Time spent in activity—% of 24 h | Comments/transformations performed |
|---|---|---|---|---|---|
Evenson et al. 2017 [ (Norway) | Age: 82.9 ± 6.3 Male:74% | LOS: 11.1 ± 7.8 Diagnoses: mixed acute | ActivPAL (PAL Technologies, Glasgow, UK) Recorded for 24 h on day 3 of admission | 8.1% ± 6.2 | All hours converted to minutes. All minutes converted to a % of 24 h |
Floegel et al. 2019 [ (USA) | Age: 78.0 ± 9.8 Male:48% | LOS: 5 ± 3.9 Diagnosis: heart failure | ActivPAL Recorded 24 h a day from recruitment to discharge | 7.3% ± 9.6 | Results for standing time (5.30% ± 4.2) and ambulating time (1.97% ± 8.6) summed with a pooled SD |
| Karlsen et al. 2017 [ | Age: 85 ± 7.2 Male:35% | LOS: 12.0 ± 6.0 Diagnoses: mixed acute | ActivPAL Recorded 24 h/day from day 2 until discharge or day 13, whichever sooner | 8.3% ± 6.6 | Authors provided dataset with results for excluded participant groups removed—analysis performed on raw data provided |
| Rowlands et al. 2014 [ | Age: 75.9 ± 9.7 Male:40% | LOS: NR Diagnosis: acute exacerbation of COPD | ActivPAL Recorded 24 h/day from day 2 of admission for 1–2 days | 7.7% ± 5.6 | All hours converted to minutes. All minutes converted to a % of 24 h |
| Villumsen et al. 2015 [ | Age: 84 ± 6.3 Male:40% | LOS: 14.2 ± 8.3 Diagnoses: mixed acute | ActivPAL Recorded 24 h/day from day 3 to discharge | 5.5% ± 6 | Median results converted to mean. Minutes converted to a % of 24 h |
Brown et al. 2009 [ (USA) | Age: 74.0 ± 6.5 Male:100% | LOS: 5.2 ± 5.3 Diagnoses: mixed acute | Augmentech Recorded for 7 days or until discharge, whichever sooner | 3.8% ± 3.5 | No transformation required |
| Pedersen et al. 2012 [ | Age: 83.5 ± 6.6 Male: 55% | LOS: 7.7 ± 1.5 Diagnoses: mixed acute | Augmentech Applied within 48 h of admission, recorded 24 h/day for 10 days or discharge, whichever sooner | 4.5% ± 3.3 | Median results converted to mean. All hours converted to minutes. All minutes converted to a % of 24 h. 4.2% of time unaccounted for in original results. Non-ambulatory patients in study as immobility reference excluded from this review |
All figures mean ± standard deviation (SD) unless stated. N number of participants, LOS length of stay
Active time recorded over variable timeframe
| Study | Participant information | Length of stay (days), disease characteristics | Method/device, duration of recording | Time spent in activity – variable timeframe | Comments/transformations performed |
|---|---|---|---|---|---|
| Belala et al. 2019 [ | Number ( Age: 84 ± 6.8 Male: 40% | LOS: 16.9 ± 16.9 Diagnoses: Mixed acute + mild-moderate cognitive impairment | Behavioural Mapping Duration: 10 h (0900–1900), excl. 2 × 45 min breaks Observations: 1 min every 15 mins | 13.9% | Inactive time was provided—active time has been extrapolated. SD not available |
| Pitta et al. 2006 [ | Age: 69 ± 14.55 Male: 94% | LOS: 10 days according to local COPD protocol, 3 stayed longer for medical reasons Diagnosis: Acute exacerbation of COPD | Dynaport MoveMonitor Duration: 12 h (0830–2030). Data collected on day 2 and 7 of admission | 10.7% ± 11.6 | Median results converted to mean. Data collected on the 2nd and 7th. Day of admission only—these results have been averaged |
| Valkenet et al. 2019 [ | Age: 72.1 ± 10.3 Male: 63% | LOS: 12.9 ± 7.4 Diagnoses: Mixed acute | Dynaport MoveMonitor Duration: 7 h (0900–1600) | 8.8% ± 5 | Authors provided dataset with results for excluded participant groups removed. Analysis has been performed on raw data provided |
All figures mean ± standard deviation (SD) unless stated. N number of participants, LOS length of stay
Daily Step count
| Study | Participant information | Length of stay (LOS) (days), disease characteristics | Device, duration of recording | Mean steps | Comments/transformations performed |
|---|---|---|---|---|---|
| Villumsen et al. 2015 [ | Age: 84 ± 6.3 Male:40% | LOS: 14.2 ± 8.3 Diagnoses: mixed acute | ActivPAL Recorded 24hrs/day from day 3 to discharge | Daily steps: 554 ± 836.5 | Median results converted to mean |
| Ueda et al. 2016 [ | Age: 82.4 (Whole group) Male: 49% (Whole group) | LOS: 18.1 (Whole group) Diagnoses: heart failure | Mediwalk Pedometer recorded day 2 of admission until day 10 | Daily steps: 259.8 ± 389.5 | Median results converted to mean. Oral and IV group results for mean age, LOS and steps were combined. Pedometer data available for 45/50 participants (age, gender and LOS are whole group results) |
| Fisher et al. 2016 [ | Age: 76.3 ± 7 Male: 29% | LOS: 5.2 ± 4.3 Diagnoses: mixed acute | StepWatch Activity Monitor (SAM) Recording 24 h/day from admission to discharge | Steps/24 h: 765 ± 850.4 | Median results converted to mean |
| Lim et al. 2018 [ | Age: 87.8 ± 4.8 Male: 47% | LOS: Mean no. of days recorded: M 4.8. F 3.8 Diagnoses: mixed acute | SAM Recorded 24 h/day for 7 days or until discharge, whichever sooner | Daily steps: 1162.3 ± 914.5 | Median results converted to mean. Lower limb accelerometery data only extracted |
| McCullagh et al. 2016 [ | Age: 77.5 ± 7.4 Male: 50% | LOS: 8.1 ± 5.4 Diagnoses: mixed acute | SAM Recorded continuously for first 7 days or until discharge, whichever sooner | Daily steps: 764.4 ± 706 | No transformation required |
| Ostir et al. 2013 [ | Age: All 65 + Male:34% | LOS: Whole group mean not reported Diagnoses: mixed acute | SAM Applied within 24 h of admission, recorded until discharge | Steps/24 h: 883.5 ± 1289.7 | Median results converted to mean. Data was collected on the 1st and last 24 h of admission only—these results have been averaged |
| Floegel et al. 2019 [ | Age: 78.0 ± 9.8 Male:48% | LOS: 5 ± 3.9 Diagnosis: heart failure | Tractivity Recorded 24 h/day from recruitment to discharge | Steps/24 h: 1447 ± 1184 | No transformation required |
| Sallis et al. 2015 [ | Age: All over 65 Male: 43% (whole group) | LOS: 3.98 ± 3.8 (whole group) Diagnoses: mixed acute | Tractivity Recorded 24 h/day from admission to discharge | Steps/24hrs: 1132 ± 1202.9 | Data collected on 1st and last 24hrs of admission only – these results have been averaged. Age, gender and LOS details not available for subset of interest (medical patients 65 +) |
All figures mean ± standard deviation (SD) unless stated
N number of participants, LOS length of stay, IV intravenous, SAM StepWatch Activity Monitor, M male, F female
Summary of functional change results
| Study ID | Measure and protocol | Functional change |
|---|---|---|
| Karlsen et al. 2017 [ | Changes in function were assessed three times during the stay using the deMorton Mobily Index (DEMMI), 30 s Chair Stand Test (30sCST)and Hand grip strength | Results for subset of patient in this review unavailable. Results for all patients, including participants excluded from this review: DEMMI: Score improved by a mean of + 4.2 between test 1 and 3 30sCST: Score improved by a mean of + 1.2 between test 1 and 3 Handgrip strength unchanged |
| Pitta et al. 2006 [ | Quadricep Force (in Newton Metres) was recorded on day 3 and 8 | Median Quadricep force declined from Day 3 (98, IQR 79–126) to Day 8 (90, IQR 67–109) |
| Ueda et al. 2016 [ | Changes in function were assessed at baseline and day 10 of admission using the Barthel Index (BI) and Functional Independence Measure (FIM) | Mean score calculated from average of both cohorts show that both BI and FIM scores declined during admission: BI: Baseline: 92.4 ± 12.9. Day 10: 68.9 ± 29.5 FIM: Baseline: 113.8 ± 13.5. Day 10: 97.1 ± 28.8 |
| Villumsen et al. 2015 [ | Changes in function assessed at admission and discharge by a physiotherapist using Timed Up and Go (TUG) and BI scores | TUG: Minority of participants (40.3%) performed better on discharge. BI Score: Majority of participants (73%) performed better on discharge |
All figures mean ± standard deviation (SD) unless stated
DEMMI De Morton Mobility Index, 30sCST 30 s Chair Stand Test, BI Barthel Index, QF Quadriceps force, TUG timed up and go
Sub-group analyses
| Group | Participants ( | Results (Mean ± SD) | 95% Confidence interval | |
|---|---|---|---|---|
| 413 | 6.6% ± 6.3 | |||
| 24 hr PA Studies at lower risk of bias [ | 65 | 7.8% ± 7.8 | 0.169 | − 2.906 to 0.506 |
| 24 hr PA studies of Heart Failure patients [ | 27 | 7.3% ± 9.6 | 0.590 | − 3.247 to 1.847 |
| 24 hr PA studies of COPD patients [ | 10 | 7.7% ± 5.6 | 0.585 | − 5.043 to 2.843 |
| 1039 | 881.8 ± 1068.2 | |||
| Step count studies at lower risk of bias [ | 405 | 875.8 ± 1106.2 | 0.924 | − 117.883 to 129.883 |
| Step count studies of heart failure patients [ | 72 | 705 ± 970.8 | 0.172 | − 76.918 to 430.518 |